The Myeloma Crowd Launches HealthTree® Aimed at Accelerating a Cure for Multiple Myeloma
Clinical Trial: Phase II Antibody Drug Conjugate Trial for Relapsed/Refractory Myeloma Patients
Engineered Toxin Bodies (EBTs), a New Treatment Approach for Multiple Myeloma
Scottsdale Round Table - October 14, 2018
New Jersey: Hackensack Meridian Health's New Myeloma Institute
The Three Most Common Genes for African American Multiple Myeloma Patients
Higher Risk of MGUS in Immediate Family Members with Multiple Myeloma
Stem Cell Transplant as a Multiple Myeloma Immunotherapy
Stating the Obvious: Having Drug Insurance Coverage Improves Outcomes for Myeloma Medicare Patients
MRD Test by Adaptive (clonoSEQ) Gains FDA Approval in Multiple Myeloma
Racial Disparities in Multiple Myeloma with Ashraf Badros, MD, University of Maryland
Dr. Badros shares his insights and research of multiple myeloma for the black community
Obesity in Myeloma: Abdominal Fat Better than BMI to Predict Multiple Myeloma
CAR T Therapy Update by Edward Stadtmauer, MD, University of Pennsylvania
Swimming As Exercise: Have You Tried It?
Putting One Foot In Front of the Other: Why Multiple Myeloma Patient Paula Waller Chooses to Keep Moving
In Memory of Multiple Myeloma Patient John Runyon
Multiple Myeloma HealthTree Stories: Brenda Jenkins
The Largest Ever Myeloma Screening PROMISE Study with Irene Ghobrial, MD, Dana Farber Cancer Institute and the SU2C Dream Team
Dr. Irene Ghobrial shares the new PROMISE study, the biggest myeloma screening study ever run
Patient Power: Endless Benefits of Yoga for Cancer Patients
Amgen Advances the Immunotherapy Race in Multiple Myeloma
The new GSK Antibody Drug Conjugate in Multiple Myeloma with Dr. Maria Chaudhry, OSU James Cancer Center
A new drug by GlaxoSmithKlein drew attention at last year's American Society of Hematology (ASH) meeting for multiple myeloma patients.
Overcoming Barriers to Being Active with Multiple Myeloma: Michelle's Story
Earlier Treatment for Some Smoldering Myeloma Patients? Dana Farber Researchers Study Smoldering Myeloma Genetic Features
Paul Butler: Making Exercise a Priority as a Myeloma Patient
